EcoDrugPlus


Trade Names	KALEXATE KAYEXALATE KIONEX SODIUM POLYSTYRENE SULFONATE SPS
Synonyms	Amberlite forte ir 120 Amberlite ir 120 Amberlite ir-120 Amberlite ir120 h Amberlite irp-69 Amberlite irp-69m Amberlite irp69 Ir 120 Kalexate Kayexalate Kionex Polistirex acid Polystyrene Sulfonate Polystyrene sulfonate Polystyrene sulfonic acid Polystyrene sulphonate Resonium a Sodium polistirex Sodium polystyrene sulfonate Sodium polystyrene sulphonate
Status
Molecule Category	UNKNOWN
UNII	1699G8679Z

Trade Names

KALEXATE

KAYEXALATE

KIONEX

SODIUM POLYSTYRENE SULFONATE

SPS

Synonyms

Amberlite forte ir 120

Amberlite ir 120

Amberlite ir-120

Amberlite ir120 h

Amberlite irp-69

Amberlite irp-69m

Amberlite irp69

Ir 120

Kalexate

Kayexalate

Kionex

Polistirex acid

Polystyrene Sulfonate

Polystyrene sulfonate

Polystyrene sulfonic acid

Polystyrene sulphonate

Resonium a

Sodium polistirex

Sodium polystyrene sulfonate

Sodium polystyrene sulphonate

Status

Molecule Category

UNKNOWN

UNII

1699G8679Z


Active Pharmaceutical Ingredients Bioactive chemicals	Exact Similarity SubStructure	Threshold (%) >= 70

Resources	Reference
ChEMBL	CHEMBL1201484
FDA SRS	1699G8679Z

Resources

Reference

ChEMBL

CHEMBL1201484

FDA SRS

1699G8679Z


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

SODIUM POLYSTYRENE SULFONATE

Cross References